Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-475
Closed -$9K 337
2018
Q4
$9K Hold
475
﹤0.01% 216
2018
Q3
$7K Hold
475
﹤0.01% 256
2018
Q2
$9K Hold
475
﹤0.01% 243
2018
Q1
$8K Hold
475
﹤0.01% 259
2017
Q4
$11K Hold
475
﹤0.01% 221
2017
Q3
$11K Hold
475
﹤0.01% 182
2017
Q2
$10K Hold
475
﹤0.01% 192
2017
Q1
$10K Hold
475
﹤0.01% 200
2016
Q4
$11K Hold
475
0.01% 202
2016
Q3
$12K Hold
475
0.01% 205
2016
Q2
$10K Hold
475
0.01% 187
2016
Q1
$9K Hold
475
0.01% 162
2015
Q4
$9K Hold
475
0.01% 151
2015
Q3
$10K Hold
475
0.01% 142
2015
Q2
$13K Hold
475
0.01% 148
2015
Q1
$12K Buy
+475
New +$11.4K 0.01% 155

Roble Belko & Company's SPA Position: Q1 2019 in Review

Roble Belko & Company sold out of Sparton (SPA) in Q1 2019, closing a stake of 475 shares — an estimated $9K sold.

Roble Belko & Company first reported a position in SPA in Q1 2015 and held it in 16 quarters. The position peaked at $13K in Q2 2015. 0 funds tracked by Wall St. Rank hold SPA as of Q1 2019.

  • Roble Belko & Company reported no remaining Sparton position as of Q1 2019 after selling out during the quarter.
  • Roble Belko & Company sold 475 Sparton shares in Q1 2019, an estimated $9K.
  • Roble Belko & Company first reported a position in Sparton in Q1 2015 and held it in 16 quarters.
  • Roble Belko & Company's Sparton position peaked at $13K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Sparton as of Q1 2019.

Based on Roble Belko & Company's 13F filing for Q1 2019, filed 10 May 2019.